denovoMATRIX
- Company typePrivate
- Founded2018
- HeadquartersDresden, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
denovoMATRIX firmographics
Firmographics- Name
- denovoMATRIX
- Website
- https://denovomatrix.com
- Company type
- Private
- Founded year
- 2018
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
denovoMATRIX industry classification
Industry- Product category
- Biomaterials for Cell Manufacturing
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials) (HLAAAGAB)
- akta.pro secondary industries
- Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH), Acellular/Decellularized Matrices & ECM Products (HLAAAGAF)
Keywords
Where denovoMATRIX is headquartered
LocationHeadquarters
- HQ city
- Dresden
- HQ country
- Germany
- HQ region
- Europe
Markets served
denovoMATRIX business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
denovoMATRIX product offering
Product offeringCore offering
denovoMATRIX designs and produces biomaterials that enable cell manufacturing in higher quality, quantity, and safety. The company supplies specialized substrate and matrix products used by researchers and developers in cell biology, cell therapy, and regenerative medicine workflows. Its portfolio supports cell expansion, differentiation, and processing for life-science and therapeutic applications.
Differentiator
Problem solved
Functional benefit
Products and services
- denovoMATRIX biomaterials for cell manufacturing
Companies that use denovoMATRIX
Customer profileIdeal customer profiles2 records
denovoMATRIX technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
denovoMATRIX partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
denovoMATRIX competitors and assessment
Company assessmentDirect peers
- BioLamina: BioLamina develops recombinant laminin (ECM) substrates for cell culture and cell therapy manufacturing. Closely comparable to denovoMATRIX because both sell defined, ECM-mimetic biomaterial coatings used to enable scalable, GMP-compatible cell manufacturing.
- CellGenix: CellGenix manufactures raw materials and ancillary reagents (cytokines, media, freeze media) for cell and gene therapy manufacturing. Highly comparable as a specialised supplier of cell-processing consumables serving the same customer base of cell therapy developers and CDMOs.
- RoosterBio: RoosterBio provides MSC and exosome manufacturing platforms, including media, cells, and bioprocess media kits for cell therapy scale-up. Comparable because it sells enabling consumables and processes aimed at industrialising cell manufacturing rather than the cells themselves.
Broad incumbents
- Corning Life Sciences: Corning supplies a broad portfolio of cell culture vessels, surfaces, and ECM coatings (including Corning Matrigel and Synthemax). Comparable as a dominant incumbent offering overlapping biomaterial and cell culture products across the same end markets.
- Thermo Fisher Scientific: Thermo Fisher offers a comprehensive cell and gene therapy workflow including media, growth factors, and cell culture consumables (Gibco, PeproTech). Comparable as a large-scale supplier serving the same cell therapy manufacturing customers with overlapping consumables categories.
- Sartorius: Sartorius provides bioprocessing solutions including cell culture media and process consumables for cell and gene therapy manufacturing. Comparable as a major incumbent in cell manufacturing inputs and adjacent workflow services.
- STEMCELL Technologies: STEMCELL Technologies supplies cell isolation, culture, and differentiation products, including defined media and substrates for cell therapy R&D and manufacturing. Comparable because it sells enabling reagents and consumables into the same cell therapy customer base.
- Lonza: Lonza operates one of the largest cell and gene therapy manufacturing CDMO businesses and also offers process development consumables. Comparable as a major incumbent shaping cell therapy manufacturing standards and qualifying raw materials.
Emerging players
- Akadeum Life Sciences: Akadeum develops buoyant microbubble cell isolation technology used in cell therapy manufacturing workflows. Comparable as an emerging, specialised supplier of cell processing consumables for the same manufacturing customers.
- Xcell Biosciences: Xcell Biosciences sells cell expansion and manufacturing platforms (avatar and related systems) targeted at cell therapy developers. Comparable as an emerging player in the cell therapy manufacturing enablement space, with overlapping customer profile.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
denovoMATRIX social profiles
Digital presencedenovoMATRIX financial estimates
Financial estimateRevenue estimate
Valuation estimate
denovoMATRIX leadership team
Management profileNumber of profiles
Profiles3 records
denovoMATRIX funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
denovoMATRIX M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about denovoMATRIX
What does denovoMATRIX do?
denovoMATRIX designs and produces biomaterials that enable cell manufacturing in higher quality, quantity, and safety. The company supplies specialized substrate and matrix products used by researchers and developers in cell biology, cell therapy, and regenerative medicine workflows. Its portfolio supports cell expansion, differentiation, and processing for life-science and therapeutic applications.
When was denovoMATRIX founded?
denovoMATRIX was founded in 2018. It employs 11 to 50 people.
Where is denovoMATRIX based?
denovoMATRIX is headquartered in Dresden, Germany, in the Europe region.
Who are denovoMATRIX's main competitors?
Direct peers on record are BioLamina, CellGenix and RoosterBio. Broad incumbents are Corning Life Sciences, Thermo Fisher Scientific, Sartorius, STEMCELL Technologies and Lonza. Emerging players are Akadeum Life Sciences and Xcell Biosciences.
Does denovoMATRIX have an API?
No public API is recorded for denovoMATRIX.
What industry is denovoMATRIX in?
denovoMATRIX's product category is Biomaterials for Cell Manufacturing. Its primary akta.pro industry code is HLAAAGAB, Tissue-Engineered Constructs & Scaffolds (natural/synthetic biomaterials), with a secondary code of HLAAABAH, Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables). Its NAICS code is 325414 and its SIC code is 2836.